# TRAVOPROST
> **ANDA210458** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2019-12-20
## Drug
- **FDA Application Number:** ANDA210458
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRAVOPROST
- **Generic name:** TRAVOPROST OPHTHALMIC SOLUTION USP, 0.004%
- **Active ingredients:** TRAVOPROST
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Discontinued
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Inc.
- **First approval:** 2019-12-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210458)
---
*AI Analytics · CC0 1.0*